Skip to content

Privacy Policy
Start Here
Research
IPO & Public Offerings
Economy & Macro
Latest
Stock Market
Market Education
Energy & Commodities
Capital Markets
Federal Reserve & Rates
About
Contact

adarx pharmaceuticals

ADARx Prices Upsized $446M Nasdaq IPO at $17 on siRNA Pipeline

September 26, 2026 by Bruno M.

AI-generated editorial image: Modern biotechnology laboratory cleanroom workbench with sterile glass vials and precision pipettes

ADARx Pharmaceuticals upsized its Nasdaq IPO to 26.25M shares at $17.00, raising $446.3M alongside an $89M AbbVie private placement.

Categories IPO & Public Offerings, Stock Market Tags adarx pharmaceuticals, adrx, biotech IPO, capital markets, sirna therapeutics

Search

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

Start Here
Market Education
Stock Market
Capital Markets
Federal Reserve & Rates

Recent Posts

Travelers Q3 Core EPS Hits $9.18 on Record Investment Income
Custodial Accounts: UTMA vs. UGMA Rules, Taxes, and Transfers
U.S. FY 2026 Deficit Reaches $1.99T as Interest Tops $1.05T
Truist Q3 Adjusted EPS Hits $1.16 on $7.7B Carlyle Loan Sale
QQQ vs. QQQM: Which Nasdaq-100 ETF Is Right for You?

Subscribe to Our Newsletter

Please leave this field empty

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

Privacy Policy
Editorial Policy
Corrections Policy
Financial Disclaimer
Contact
About Bruno M.
Investor Tools

© 2026 Equity Capital Market • Built with GeneratePress